Azenta Life Sciences is a pharmaceutical company that specializes in developing and commercializing innovative therapies for the treatment of cancer. The company's lead product candidate is a novel small molecule inhibitor of the Wnt signaling pathway, which is being developed for the treatment of various types of cancer. Azenta Life Sciences was founded in 2018 and is headquartered in Oakbrook Terrace, Illinois.